Randomized, Open, Parallel, Active Controlled Study on Fracture Prevention in Antiosteoporosis Treatment (OF Study)

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 1996

Primary Completion Date

June 30, 2005

Conditions
Osteoporosis
Interventions
DRUG

MENATETRANONE

Trial Locations (1)

856-0835

Ōmura

All Listed Sponsors
lead

Eisai Limited

INDUSTRY

NCT00165607 - Randomized, Open, Parallel, Active Controlled Study on Fracture Prevention in Antiosteoporosis Treatment (OF Study) | Biotech Hunter | Biotech Hunter